TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/12 14:34 | 10/16/12 | KYTH | Kythera Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Ii, LP | CA | T | M.d | 920 | 7.55 | 0 | 122 | 75 | I | ||||||||||||||||
9/21/09 15:54 | 9/18/09 | HLCS | Helicos Biosciences Corp | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Ii, LP | CA | T | P.d | 625 | 2.57 | 0 | 243 | 2 | 10,710 | I | ||||||||||||||||
12/29/08 16:14 | 12/23/08 | HLCS | Helicos Biosciences Corp | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Ii, LP | CA | T | P.d | 0 | 0.00 | 0 | 8,621 | 404 | 10,756 | I | ||||||||||||||||
6/1/07 16:22 | 5/30/07 | HLCS | Helicos Biosciences Corp | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Ii, LP | CA | T | P.d | 1,000 | 9.00 | 0 | 111 | 202 | 166 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |